Axa’s AngioDynamics ANGO Stock Holding History

Axa’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-104,400	Closed	-$818K	–	1065
2023 Q4	$818K	Hold	104,400	–	–	﹤0.01%	875
2023 Q3	$763K	Hold	104,400	–	–	﹤0.01%	875
2023 Q2	$1.09M	Buy	+104,400	New	+$1M	﹤0.01%	828
2020 Q4	–	Sell	-13,500	Closed	-$163K	–	1257
2020 Q3	$163K	Sell	13,500 -14,300	-51%	-$136K	﹤0.01%	1164
2020 Q2	$283K	Sell	27,800 -20,100	-42%	-$207K	﹤0.01%	1140
2020 Q1	$500K	Buy	+47,900	New	+$601K	﹤0.01%	969
2019 Q3	–	Sell	-79,633	Closed	-$1.57M	–	1300
2019 Q2	$1.57M	Sell	79,633 -95,267	-54%	-$1.94M	0.01%	891
2019 Q1	$4M	Buy	174,900 +5,900	+3%	+$128K	0.02%	702
2018 Q4	$3.4M	Sell	169,000 -17,700	-9%	-$366K	0.01%	700
2018 Q3	$4.06M	Sell	186,700 -12,100	-6%	-$269K	0.01%	725
2018 Q2	$4.42M	Sell	198,800 -21,800	-10%	-$446K	0.02%	682
2018 Q1	$3.81M	Hold	220,600	–	–	0.02%	723
2017 Q4	$3.67M	Buy	220,600 +61,100	+38%	+$1.04M	0.01%	725
2017 Q3	$2.73M	Buy	159,500 +29,440	+23%	+$495K	0.01%	765
2017 Q2	$2.11M	Buy	130,060 +3,000	+2%	+$47.4K	0.01%	776
2017 Q1	$2.2M	Hold	127,060	–	–	0.01%	761
2016 Q4	$2.14M	Buy	127,060 +45,919	+57%	+$766K	0.01%	752
2016 Q3	$1.42M	Buy	+81,141	New	+$1.32M	0.01%	836
2015 Q3	–	Sell	-59,472	Closed	-$975K	–	1445
2015 Q2	$975K	Buy	59,472 +15,725	+36%	+$261K	﹤0.01%	969
2015 Q1	$778K	Sell	43,747 -5,210	-11%	-$96.8K	﹤0.01%	1003
2014 Q4	$931K	Buy	48,957 +45,357	+1,260%	+$769K	﹤0.01%	981
2014 Q3	$49K	Buy	+3,600	New	+$51.4K	﹤0.01%	1356

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Axa's ANGO Position: Q1 2024 in Review

Axa sold out of AngioDynamics (ANGO) in Q1 2024, closing a stake of 104,400 shares — an estimated $818K sold.

Axa first reported a position in ANGO in Q3 2014 and held it in 22 quarters. The position peaked at $4.42M in Q2 2018. 135 funds tracked by Wall St. Rank hold ANGO as of Q1 2024.

Axa reported no remaining AngioDynamics position as of Q1 2024 after selling out during the quarter.
Axa sold 104,400 AngioDynamics shares in Q1 2024, an estimated $818K.
Axa first reported a position in AngioDynamics in Q3 2014 and held it in 22 quarters.
Axa's AngioDynamics position peaked at $4.42M in Q2 2018.
135 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.